Needle Free Injection Market size was valued at USD 125 million in 2021, growing at a CAGR of 17.2% from 2022-28. Due to increase in prevalence of various types of chronic diseases such as cancer, diabetes and so on, risk of exposure to communicable diseases due to needle stick injuries, and decrease in healthcare costs. Moreover, the advantage of painlessness, the wide range of applications with the needle free injection, and rise in R&D activities for the development of needle free injections are the major factors that are driving the growth of the global market over the forecast timeframe. This report studies global market dynamics elaborately to indentify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global needle free injection products.